Dudediligence.

PDS Biotechnology Corporation

PDSBNASDAQ · Pharmaceutical Preparations
Write an idea

Fundamentals

Oldest to newest
Net income, by quarter
−$10.7MSep ’24−$8.0MDec ’24−$8.5MMar ’25−$9.4MJun ’25−$9.0MSep ’25−$7.6MDec ’25−$7.3MMar ’26−$9.8MJun ’26
Fiscal years, by the month each ended
LineDec 2021Dec 2022Dec 2023Dec 2024Dec 2025
Operating income−$21.4M−$41.7M−$43.0M−$36.3M−$31.5M
Net income−$16.9M−$40.9M−$42.9M−$37.6M−$34.5M
Operating cash flow−$12.5M−$25.7M−$33.6M−$35.0M−$27.8M
Free cash flownone on filenone on file−$33.6M−$35.1M−$27.8M
Cash$65.2M$73.8M$56.6M$41.7M$26.7M
Shares outstanding28.4M30.2M33.1M38.0M54.9M